<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neuroinflammation</journal-id>
<journal-id journal-id-type="iso-abbrev">J Neuroinflammation</journal-id>
<journal-title-group>
<journal-title>Journal of Neuroinflammation</journal-title>
</journal-title-group>
<issn pub-type="epub">1742-2094</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26377554</article-id>
<article-id pub-id-type="pmc">4573939</article-id>
<article-id pub-id-type="publisher-id">388</article-id>
<article-id pub-id-type="doi">10.1186/s12974-015-0388-3</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mast cells in meningiomas and brain inflammation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Polyzoidis</surname>
<given-names>Stavros</given-names>
</name>
<address>
<email>stavrospolyzoidis@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koletsa</surname>
<given-names>Triantafyllia</given-names>
</name>
<address>
<email>koletsa@med.auth.gr</email>
</address>
<xref ref-type="aff" rid="Aff2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Panagiotidou</surname>
<given-names>Smaro</given-names>
</name>
<address>
<email>smaro.panagiotidou@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff3"></xref>
<xref ref-type="aff" rid="Aff4"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ashkan</surname>
<given-names>Keyoumars</given-names>
</name>
<address>
<email>k.ashkan@nhs.net</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Theoharides</surname>
<given-names>Theoharis C.</given-names>
</name>
<address>
<phone>(617) 636-6866</phone>
<email>theoharis.theoharides@tufts.edu</email>
</address>
<xref ref-type="aff" rid="Aff3"></xref>
<xref ref-type="aff" rid="Aff4"></xref>
<xref ref-type="aff" rid="Aff5"></xref>
<xref ref-type="aff" rid="Aff6"></xref>
<xref ref-type="aff" rid="Aff7"></xref>
</contrib>
<aff id="Aff1"><label></label>Department of Neurosurgery, Kings College London, London, UK </aff>
<aff id="Aff2"><label></label>Department of Pathology, AHEPA General Hospital, Thessaloniki, Greece </aff>
<aff id="Aff3"><label></label>Molecular Immunopharmacology and Drug Discovery, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, 136 Harrison Avenue, Suite J304, Boston, MA 02111 USA </aff>
<aff id="Aff4"><label></label>Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Tufts Medical Center, Boston, MA USA </aff>
<aff id="Aff5"><label></label>Department of Internal Medicine, Tufts University School of Medicine, Tufts Medical Center, Boston, MA USA </aff>
<aff id="Aff6"><label></label>Department of Psychiatry, Tufts University School of Medicine, Tufts Medical Center, Boston, MA USA </aff>
<aff id="Aff7"><label></label>Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, 136 Harrison Avenue, Suite J304, Boston, MA 02111 USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>17</day>
<month>9</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>17</day>
<month>9</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>12</volume>
<elocation-id>170</elocation-id>
<history>
<date date-type="received">
<day>7</day>
<month>8</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>1</day>
<month>9</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>© Polyzoidis et al. 2015</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p>Research focus in neuro-oncology has shifted in the last decades towards the exploration of tumor infiltration by a variety of immune cells and their products. T cells, macrophages, B cells, and mast cells (MCs) have been identified.</p>
</sec>
<sec>
<title>Methods</title>
<p>A systematic review of the literature was conducted by searching PubMed, EMBASE, Google Scholar, and Turning Research into Practice (TRIP) for the presence of MCs in meningiomas using the terms meningioma, inflammation and mast cells.</p>
</sec>
<sec>
<title>Results</title>
<p>MCs have been detected in various tumors of the central nervous system (CNS), such as gliomas, including glioblastoma multiforme, hemangioblastomas, and meningiomas as well as metastatic brain tumors. MCs were present in as many as 90 % of all high-grade meningiomas mainly found in the perivascular areas of the tumor. A correlation between peritumoral edema and MCs was found.</p>
</sec>
<sec>
<title>Interpretation</title>
<p>Accumulation of MCs in meningiomas could contribute to the aggressiveness of tumors and to brain inflammation that may be involved in the pathogenesis of additional disorders.</p>
</sec>
</abstract>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2015</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p>Meningiomas are primary extra-axial tumors of the central nervous system (CNS) with an incidence of ~2 in 100,000 in adults [<xref ref-type="bibr" rid="CR1">1</xref>]. There is an approximate 3:1 female predominance of these tumors mainly attributed to the action of oestrogens [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR4">4</xref>]. While meningiomas represent 15 % of intracranial, 25 % of intraspinal, and 28 % of primary CNS tumors, they usually are not at the center of research focus, probably due to their predominantly benign nature, which results in favorable outcomes. However, a minority of meningiomas is found to be more aggressive, invade brain parenchyma, present with significant degree of peritumoral edema, recur, and subsequently have an aggressive course with increased morbidity and mortality [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
<p>Meningiomas are commonly associated with headaches, imbalance, vision disturbance, and other neurologic problems [<xref ref-type="bibr" rid="CR6">6</xref>] that could be quite debilitating. Based on the 2007 (current) classification and grading system of the World Health Organization (WHO) for nervous tissue tumors [<xref ref-type="bibr" rid="CR7">7</xref>], meningiomas belong to the meningothelial-cell tumors of the meninges and are classified in three grades (Table <xref ref-type="table" rid="Tab1">1</xref>): grade I—slow growing, noncancerous; grade II—atypical with mixed noncancerous and cancerous features; and grade III—cancerous and fast growing. The vast majority of meningiomas is graded as I and is benign [<xref ref-type="bibr" rid="CR5">5</xref>] with treatment consisting solely of surgical resection, which results in recurrence rates of 2–3 % following total resection [<xref ref-type="bibr" rid="CR8">8</xref>]. For selected small or incompletely excised tumors, focused radiotherapy is an additional option [<xref ref-type="bibr" rid="CR9">9</xref>]. However, treatment of meningiomas encasing crucial neural and vascular structures, and of more aggressive histological types, such as anaplastic (grade III), can be more challenging. The current standard of care for the latter comprises surgery and additional radiotherapy, which contributes to a mean overall survival of 3.3 years for anaplastic meningiomas based on a retrospective study [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Mean progression-free survival is 11.5 and 2.7 years, respectively [<xref ref-type="bibr" rid="CR11">11</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Classification of meningiomas</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>1.   Grade I. Meningothelial, fibrous (fibroblastic), transitional (mixed),   psammomatous, angiomatous, microcystic, secretory,   lymphoplasmacyte-rich, metaplastic</td></tr><tr><td>2.   Grade II. Chordoid, clear cell, atypical, brain-invasive</td></tr><tr><td>3.   Grade III. Papillary, rhabdoid, and anaplastic (malignant)</td></tr></tbody></table></table-wrap></p>
<p>Mainstream theory about tumorigenesis of meningiomas favors origin from arachnoid cap cells, while intraventricular ones probably develop from meningothelial inclusion bodies of the tela choroidea arachnoid [<xref ref-type="bibr" rid="CR12">12</xref>]. Tumor formation can be triggered or affected by various factors, such as genetic [classically the neurofibromatosis 2 (NF2) gene] [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], previous radiotherapy, and possibly head trauma [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Meningiomas can be infiltrated by various types of cells, mainly of the immune system, such as macrophages, CD8 lymphocytes, and mast cells (MCs) [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Some meningioma variants have been associated with systematic inflammatory syndromes as well, for example, Castleman’s syndrome [<xref ref-type="bibr" rid="CR19">19</xref>]. This could either represent an innate immune response to the newly forming tumor or could be a factor contributing to tumorigenesis. As such, it has been shown that common variations in the genetics of the innate immune system, such as T-cell regulation, chronic inflammation, IgE, and allergic reactions, may increase the risk of meningioma [<xref ref-type="bibr" rid="CR20">20</xref>–<xref ref-type="bibr" rid="CR24">24</xref>]. Presently, the exact nature of this interaction between meningiomas and the immune system, and its potential effect on tumor growth, remains unclear.</p>
<p>A retrospective immunohistochemical study investigated mononuclear cell infiltration in a series of 34 meningiomas [<xref ref-type="bibr" rid="CR18">18</xref>]. Such infiltrates mainly comprised of T cells and macrophages, with the latter being significantly associated with high cellularity, nuclear atypia, and frequent mitotic figures intra- and perivascularly. MCs were seen in 9/32 (28 %) tumors, among which the most prevalent subtype was the syncytial in agreement with previous studies. Prognostic significance of this finding was unclear in this study.</p>
<p>MCs of various phenotypes were found mainly perivascularly and sporadically in lobules of connective tissue in all types of meningiomas, including malignant ones independent of growth rate, grading, and the degree of calcification [<xref ref-type="bibr" rid="CR25">25</xref>].</p>
<p>A rare case of a convexity meningioma with an unusually high number of MCs, which presented as chronic subdural hematoma, was described by Popovic et al. [<xref ref-type="bibr" rid="CR26">26</xref>]. It was suggested that intratumoral histamine release, histamine-associated vasodilation, and subsequent tumoral hemorrhage in MC-rich meningiomas may be an underlying mechanism in a small proportion of meningioma-related subdural hematomas.</p>
<p>Incidental findings on meningiomas and MCs have also been reported in the context of studies with other objectives. During examination of the distribution of the glial fibrillary acidic protein (GFAP) in 131 paraffin-embedded sections of brain neoplasms deriving from either surgical or postmortem specimens [<xref ref-type="bibr" rid="CR27">27</xref>], MCs were identified in one case of meningothelial meningioma [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
</sec>
<sec id="Sec2" sec-type="materials|methods">
<title>Methods</title>
<sec id="Sec3">
<title>Objectives</title>
<p>The aim of this study was to review the literature investigating the presence of MCs in meningiomas and their potential interaction. More specifically, the literature was reviewed for the role of this interface and its contribution to tumorigenesis, biological behavior, tumor growth, and tumor suppression.</p>
</sec>
<sec id="Sec4">
<title>Selection of articles</title>
<p>A systematic review of the literature was conducted by a thorough online search in PubMed, EMBASE, Google Scholar, and Turning Research into Practice (TRIP) to retrieve all articles evaluating the presence and role of MCs in intracranial meningiomas. In the PubMed MeSH database system, we used the terms <italic>meningioma, inflammation</italic> and <italic>mast cells [“Meningiomas” (Mesh) AND “Mast cells” (Mesh)]</italic>. Furthermore, to eliminate the chance of missing any other published data, references from past relevant publications were also evaluated. Perspective and retrospective clinical studies, including case reports, as well as experimental studies in animals were included only in the English language.</p>
</sec>
</sec>
<sec id="Sec5" sec-type="results">
<title>Results</title>
<sec id="Sec6">
<title>Mast cells in brain inflammation</title>
<p>There is growing interest is the presence of MCs in meningiomas, because of the conflicting reports with regard to the association of MCs with meningioma grade [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. Furthermore, there is increasing evidence suggesting MCs may stimulate neoplastic growth [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>], while others support a potential dual role of MCs contributing both to tumorigenesis and tumor-suppression processes in various types of cancers [<xref ref-type="bibr" rid="CR33">33</xref>].</p>
<p>MCs originate from a bone marrow progenitor and subsequently develop different phenotype characteristics locally in tissues. Their range of functions is wide and includes participation in allergic reactions, innate and adaptive immunity, inflammation, and autoimmunity [<xref ref-type="bibr" rid="CR34">34</xref>]. In the human brain, MCs can be located in various areas, such as the pituitary stalk, the pineal gland, the area postrema, the choroid plexus, thalamus, hypothalamus, and the median eminence [<xref ref-type="bibr" rid="CR35">35</xref>]. In the meninges, they are found within the dural layer in association with vessels and terminals of meningeal nociceptors [<xref ref-type="bibr" rid="CR36">36</xref>]. MCs have a distinct feature compared to other hematopoietic cells in that they reside in the brain [<xref ref-type="bibr" rid="CR37">37</xref>]. MCs contain numerous granules and secrete an abundance of prestored mediators such as corticotropin-releasing hormone (CRH), neurotensin (NT), substance P (SP), tryptase, chymase, vasoactive intestinal peptide (VIP), vascular endothelial growth factor (VEGF), TNF, prostaglandins, leukotrienes, and varieties of chemokines and cytokines some of which are known to disrupt the integrity of the blood-brain barrier (BBB) [<xref ref-type="bibr" rid="CR38">38</xref>–<xref ref-type="bibr" rid="CR40">40</xref>].</p>
<p>They key role of MCs in inflammation [<xref ref-type="bibr" rid="CR34">34</xref>] and in the disruption of the BBB [<xref ref-type="bibr" rid="CR41">41</xref>–<xref ref-type="bibr" rid="CR43">43</xref>] suggests areas of importance for novel therapy research. Increasing evidence also indicates that MCs participate in neuroinflammation directly [<xref ref-type="bibr" rid="CR44">44</xref>–<xref ref-type="bibr" rid="CR46">46</xref>] and through microglia stimulation [<xref ref-type="bibr" rid="CR47">47</xref>], contributing to the pathogenesis of such conditions such as headaches, [<xref ref-type="bibr" rid="CR48">48</xref>] autism [<xref ref-type="bibr" rid="CR49">49</xref>], and chronic fatigue syndrome [<xref ref-type="bibr" rid="CR50">50</xref>]. In fact, a recent review indicated that peripheral inflammatory stimuli can cause microglia activation [<xref ref-type="bibr" rid="CR51">51</xref>], thus possibly involving MCs outside the brain.</p>
</sec>
<sec id="Sec7">
<title>Mast cells in meningiomas</title>
<p>MCs have been found to infiltrate both primary and metastatic tumors [<xref ref-type="bibr" rid="CR52">52</xref>]. For instance, MCs infiltrated and proliferated both in the tumor mass and in the area adjacent to tumor-associated vessels in an experimental model of high-grade gliomas, including glioblastoma multiforme [<xref ref-type="bibr" rid="CR53">53</xref>]. In addition, stem cell factor (SCF), the main growth factor of MCs, was mainly expressed around the tumor-associated vessels, and it was proposed that the tumor-derived CXCL12/CXCR4 attracted MCs [<xref ref-type="bibr" rid="CR53">53</xref>].</p>
<p>Polajeva et al. reported that MCs were detected in both low- and high-grade gliomas [<xref ref-type="bibr" rid="CR54">54</xref>], and it was concluded that (a) MC accumulation in these tumors increased as grade malignancy increased, (b) neutralization of the glioma-derived macrophage migration inhibitory factor (MIF) reduced the extent of MC migration, (c) the magnitude of MC recruitment correlated with the level of MIF, and (d) MIF-induced accumulation of MCs in vivo was associated with activation of the signal transducer and activator of transcription 5 (STAT5) [<xref ref-type="bibr" rid="CR54">54</xref>]. Additionally, MCs have been detected in increased numbers in the infiltrating zones of medulloblastomas and gliomas [<xref ref-type="bibr" rid="CR55">55</xref>], while they were also found to be erythropoietin (EPO)-positive in 50 % of a series of hemangioblastoma specimens [<xref ref-type="bibr" rid="CR56">56</xref>].</p>
<p>Moreover, it has been proposed that metastatic brain tumors can be promoted by stress (unavoidable in patients with cancer) [<xref ref-type="bibr" rid="CR57">57</xref>] which activates brain MCs to disrupt the BBB via the CRH pathway [<xref ref-type="bibr" rid="CR58">58</xref>]. This increases BBB permeability for primary cancer cells deriving from the periphery, which can subsequently infiltrate brain parenchyma and metastasize as was shown for rat mammary adenocarcinoma [<xref ref-type="bibr" rid="CR59">59</xref>]. In two case reports, breast cancer cells were reported to be associated with meningiomas [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>] and breast cancer may be concurrent with meningiomas [<xref ref-type="bibr" rid="CR62">62</xref>]. Immune responses, such as the peritumoral collection of MCs, are increasingly considered to augment tumor growth and metastasis [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR63">63</xref>].</p>
<p>Two retrospective studies [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR29">29</xref>] evaluated MCs, by tryptase immunostaining, in a series of meningiomas of various grades. Specimens were divided in two groups of low-grade meningiomas (WHO grade I) and high-grade meningiomas (WHO grades II and III). In the first study [<xref ref-type="bibr" rid="CR24">24</xref>], 70 cases were analyzed. In the group of low-grade tumors (<italic>n</italic> = 63), MCs were seen in 20/63 cases (31.8 %), with strong diffused immunoreaction in 8/20 mostly next to blood vessels disseminated intratumorally; all psammomatous, secretory, and meningothelial meningiomas were negative for MCs, whereas all fibrous and transitional meningiomas were positive. Interestingly, CT brain images of all MC-positive low-grade meningiomas showed marked peritumoral edema [<xref ref-type="bibr" rid="CR24">24</xref>].</p>
<p>In the second group (<italic>n</italic> = 7), 6/7 (86 %) tumors were positive for MCs and all presented with peritumoral edema on CT. One anaplastic meningioma was strongly immunopositive, while the rest of the high-grade meningiomas showed focal, but disseminated, positive immunoreaction for tryptase [<xref ref-type="bibr" rid="CR24">24</xref>]. The second study [<xref ref-type="bibr" rid="CR29">29</xref>], was conducted on 154 cases, and apart from MCs, it also evaluated the expression of hypoxia-inducible factor-1 (HIF-1), which is a marker of hypoxia found to be correlated with grade and progression of many cancers including glioblastoma [<xref ref-type="bibr" rid="CR64">64</xref>]. In the group of low-grade meningiomas (<italic>n</italic> = 104), MCs were seen in 42 cases (40.4 %), with strong diffused immunoreaction in 17/42. In the group of high-grade meningiomas (<italic>n</italic> = 50), 45 (90 %) of tumors were positive for MCs, with strong immunoreaction in 6/45 cases. MCs were observed not only next to blood vessels but also within the tumor [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
<p>Based on the Steinhoff classification of peritumoral edema [<xref ref-type="bibr" rid="CR65">65</xref>], this study showed a statistically significant association between HIF-1 expression, tryptase expression, and the presence of peritumoral brain edema, as well as between MC accumulation and HIF-1 expression based on meningioma grading [<xref ref-type="bibr" rid="CR29">29</xref>]. MC mediators such as histamine, serotonin, or VEGF might significantly contribute to the formation of peritumoral edema.</p>
<p>Tirakotai et al. studied secretory meningiomas (grade I), which were found to be infiltrated by a higher number of MCs compared to other types (nonsecretory meningiomas). Higher number of MCs was found mainly in and around the pseudopsammoma bodies of secretory meningiomas [<xref ref-type="bibr" rid="CR66">66</xref>] Eparil et al. and Tina-Suck et al. investigated 12 and 10 cases, respectively, of chordoid meningiomas (grade II) [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR68">68</xref>]. Both reported a significant number of MCs in this meningioma variant. The first observed MCs both within the myxoid stroma and the epithelial cell islands, by using toluidine blue and Giemsa stains, in 100 % of cases. MCs were sparsely populated, granulated, single in arrangement, and more frequently seen at the interface regions [<xref ref-type="bibr" rid="CR67">67</xref>]. The second observed MCs present both in the connective tissue stroma and the epithelial cell islands in all specimens, using positive Periodic Acid Schiff (PAS) and mucicarmine stains [<xref ref-type="bibr" rid="CR68">68</xref>]. In contrast, another study [<xref ref-type="bibr" rid="CR30">30</xref>] reported that MCs had poor associations with meningioma tumor grading.</p>
</sec>
<sec id="Sec8">
<title>Mast cells in cystic meningiomas</title>
<p>An interesting role of MCs in meningiomas was revealed in a retrospective study investigating microcystic and cystic changes in 397 meningiomas [<xref ref-type="bibr" rid="CR69">69</xref>]. Such changes were present in about 10 % of these tumors, mainly of the meningothelial type (grade I), and were associated with permeability disturbances and increased number of MCs. Here we show the presence of MCs in dura and bone infiltrated by meningioma of the meningothelial type grade 1 stained for tryptase (Fig. <xref ref-type="fig" rid="Fig1">1</xref>) and CD117 (c-kit, the tyrosine kinase surface receptor for stem cell factor) (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). It should be noted that these MCs do not appear degranulated. We recently reported that MCs infiltrating pancreatic adenocarcinoma were also increased, but not degranulated in contrast to MCs in acute pancreatitis that were increased in number, but degranulated [<xref ref-type="bibr" rid="CR70">70</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><p>Photomicrographs of tissue samples of dura and bone infiltrated by meningioma of the meningothelial type grade I obtained from a brain lesion following a left-left frontotemporal craniectomy. Mast cells were stained immunohistochemically for the presence of tryptase (<italic>brown color</italic>). <bold>a</bold> Dura showing the upper unaffected part and the lower part infiltrated meningioma cells (<italic>blue</italic>) and accumulated mast cells (<italic>brown</italic>); magnification = ×40. <bold>b</bold> Unaffected dura; magnification = ×100. <bold>c</bold> Bone infiltrated by meningioma cells showing a cluster of mast cells; magnification = ×100. <bold>d</bold> Mast cells surrounding clusters of meningioma cells infiltrating the dura; magnification = ×400. <bold>e</bold> One mast cell surrounded by meningioma cells; this mast cell does not appear to be degranulated. Bar = 15 μm</p></caption><graphic id="MO1" xlink:href="12974_2015_388_Fig1_HTML"></graphic></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Photomicrographs of tissue samples of dura infiltrated by meningioma of the meningothelial type grade I obtained from a brain lesion following a left-left frontotemporal craniectomy. Mast cells were stained immunohistochemically for the presence of CD117 (<italic>brown color</italic>). <bold>a</bold> Unaffected dura showing two mast cells. <bold>b</bold> Dura infiltrated by meningioma cells showing a number of mast cells (<italic>brown color</italic>). Magnification = ×200</p></caption><graphic id="MO2" xlink:href="12974_2015_388_Fig2_HTML"></graphic></fig></p>
</sec>
<sec id="Sec9">
<title>Meningiomas and perivascular edema</title>
<p>Cerebral edema is quite common in intracranial meningiomas. In one study of 68 meningiomas evaluated by computed tomography, 40 % had significant edema [<xref ref-type="bibr" rid="CR71">71</xref>]. Another review concluded that intracranial meningiomas were associated with brain edema in 50–66 % of cases [<xref ref-type="bibr" rid="CR72">72</xref>]. In fact, edema has been considered a prognostic factor for meningiomas and metastases, but not gliomas [<xref ref-type="bibr" rid="CR73">73</xref>]. Moreover, there was a strong correlation between brain edema and shape of tumor margins and signal intensity on magnetic resonance imaging of 51 meningiomas studied [<xref ref-type="bibr" rid="CR74">74</xref>]. Peritumoral edema may be due to increased expression of vascular endothelial growth factor (VEGF) [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>]. In fact, meningiomas can secrete VEGF-A themselves [<xref ref-type="bibr" rid="CR77">77</xref>]. It is of interest that MCs can secrete large quantities of VEGF especially in response to CRH [<xref ref-type="bibr" rid="CR78">78</xref>], which can be secreted by MCs [<xref ref-type="bibr" rid="CR79">79</xref>] and by metastatic cancer cells [<xref ref-type="bibr" rid="CR80">80</xref>].</p>
<p>Meningiomas are well known to present with severe headaches, even when tumors are small with little edema, and mass effect alone is insufficient to account for this symptom [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]. It is therefore of interest that MCs have been implicated in the pathogenesis of migraines [<xref ref-type="bibr" rid="CR38">38</xref>] and meningeal MC-neuron interactions are increasingly invoked in the pathophysiology of headaches [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR84">84</xref>]. Meningeal inflammation was also regarded critical in seizures [<xref ref-type="bibr" rid="CR85">85</xref>], and there have been a number of cases of patients with seizures due to underlying mastocytosis [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR86">86</xref>].</p>
<p>The association of MCs with perivascular edema is also important because it may indicate disruption of the BBB, which worsens by stress and contributes to brain metastases [<xref ref-type="bibr" rid="CR57">57</xref>], multiple sclerosis [<xref ref-type="bibr" rid="CR87">87</xref>], autism [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR88">88</xref>], and brain “fog” [<xref ref-type="bibr" rid="CR89">89</xref>]. It may, therefore, be important to investigate the presence of occult meningiomas in such disorders.</p>
</sec>
<sec id="Sec10">
<title>Treatment options</title>
<p>Brain edema may be reduced with the use of glucocorticoids or anti-angiogenic therapy [<xref ref-type="bibr" rid="CR77">77</xref>].</p>
<p>Cyclooxygenase (COX) inhibitors have also been considered for the treatment of brain edema [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR90">90</xref>] especially because COX-2 expression has been reported in astrocyte and microglia in humans [<xref ref-type="bibr" rid="CR91">91</xref>]. It is of interest that certain natural flavonoids, such as quercetin (3, 5, 7-3΄ 4΄-pentahydroxyflavone), inhibit COX-2 and angiogenesis [<xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR93">93</xref>], and its structural analog luteolin (5,7-3′4′-tetrahydroxyflavone) inhibits COX-2 in glioblastoma cells [<xref ref-type="bibr" rid="CR94">94</xref>]. Quercetin also has antiproliferative activity against human meningiomas [<xref ref-type="bibr" rid="CR95">95</xref>] and gliomas [<xref ref-type="bibr" rid="CR96">96</xref>, <xref ref-type="bibr" rid="CR97">97</xref>]. Luteolin has synergistic action with COX-2 inhibitors on inducing apoptosis of breast cancer cells [<xref ref-type="bibr" rid="CR98">98</xref>].</p>
<p>Both quercetin [<xref ref-type="bibr" rid="CR99">99</xref>] and luteolin inhibit MCs [<xref ref-type="bibr" rid="CR99">99</xref>–<xref ref-type="bibr" rid="CR101">101</xref>], especially MC-derived VEGF release. Luteolin also inhibits activation of auto-immune T cells [<xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR103">103</xref>].</p>
<p>A methylated luteolin analog (6-methoxyluteolin) was shown to inhibit IgE-stimulated histamine release from human basophilic KU812F [<xref ref-type="bibr" rid="CR104">104</xref>]. Moreover, we recently showed that tetramethoxyluteolin is a more potent inhibitor of human cultured MCs than luteolin [<xref ref-type="bibr" rid="CR105">105</xref>].</p>
<p>Luteolin also inhibits activation and proliferation of microglia [<xref ref-type="bibr" rid="CR106">106</xref>–<xref ref-type="bibr" rid="CR109">109</xref>], which have been implicated in autism [<xref ref-type="bibr" rid="CR110">110</xref>]. A luteolin/quercetin-containing formulation in olive fruit oil significantly improved attention and behavior in children with autism [<xref ref-type="bibr" rid="CR111">111</xref>, <xref ref-type="bibr" rid="CR112">112</xref>]. It is interesting that oleocanthal present in olive oil was shown to have COX inhibitory activity [<xref ref-type="bibr" rid="CR113">113</xref>].</p>
<p>Flavonoids are naturally occurring compounds found mostly in green plants, herbs, and seeds with potent antioxidant, anti-inflammatory, and anticancer properties [<xref ref-type="bibr" rid="CR114">114</xref>]. Recent reviews have discussed the use of flavonoids in neuropsychiatric [<xref ref-type="bibr" rid="CR115">115</xref>, <xref ref-type="bibr" rid="CR116">116</xref>] and neurodegenerative [<xref ref-type="bibr" rid="CR117">117</xref>, <xref ref-type="bibr" rid="CR118">118</xref>] diseases, especially luteolin in the prevention and/or treatment of brain fog [<xref ref-type="bibr" rid="CR119">119</xref>].</p>
</sec>
</sec>
<sec id="Sec11" sec-type="conclusion">
<title>Conclusion</title>
<p>There is growing evidence that the accumulation of MCs in meningiomas, mainly in perivascular areas, is associated with the presence of peritumoral edema, especially in high-grade tumors. Furthermore, meningeal MCs may contribute to edema and inflammation involved in headaches and possibly seizures. Finally, meningeal MCs may regulate permeability of the BBB and contribute to the pathogenesis of brain metastases, multiple sclerosis, and autism.</p>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>
<bold>Competing interest</bold>
</p>
<p>The authors declare that they have no competing interests.</p>
</fn>
<fn>
<p>
<bold>Authors’ contributions</bold>
</p>
<p>SP carried out most of the literature search and wrote the original draft of the paper. TK carried out the immunohistochemical staining and produced the photomicrographs used. SP reviewed the literature and prepared the manuscript. KA provided information on the classification and reviewed the paper critically. TCT conceived the original concept, reviewed all the literature and the immunohistochemical findings, corrected earlier drafts of the manuscript, and prepared the final manuscript. All authors read and approved the final manuscript.</p>
</fn>
</fn-group>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogers</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Barani</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Chamberlain</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kaley</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>McDermott</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Raizer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schiff</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Vogelbaum</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review</article-title>
<source/>J Neurosurg
          <year>2015</year>
<volume>122</volume>
<fpage>4</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.3171/2014.7.JNS131644</pub-id>
<pub-id pub-id-type="pmid">25343186</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carroll</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>PM</given-names>
</name>
</person-group>
<article-title>Expression of estrogen receptors alpha and beta in human meningiomas</article-title>
<source/>J Neurooncol
          <year>1999</year>
<volume>42</volume>
<fpage>109</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1023/A:1006158514866</pub-id>
<pub-id pub-id-type="pmid">10421067</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maxwell</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Galanopoulos</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Neville-Golden</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Antoniades</surname>
<given-names>HN</given-names>
</name>
</person-group>
<article-title>Expression of androgen and progesterone receptors in primary human meningiomas</article-title>
<source/>J Neurosurg
          <year>1993</year>
<volume>78</volume>
<fpage>456</fpage>
<lpage>462</lpage>
<pub-id pub-id-type="doi">10.3171/jns.1993.78.3.0456</pub-id>
<pub-id pub-id-type="pmid">8433149</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Probst-Cousin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Villagran-Lillo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lahl</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bergmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Gullotta</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Secretory meningioma: clinical, histologic, and immunohistochemical findings in 31 cases</article-title>
<source/>Cancer
          <year>1997</year>
<volume>79</volume>
<fpage>2003</fpage>
<lpage>2015</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1097-0142(19970515)79:10&lt;2003::AID-CNCR23&gt;3.0.CO;2-X</pub-id>
<pub-id pub-id-type="pmid">9149029</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ostrom</surname>
<given-names>QT</given-names>
</name>
<name>
<surname>Gittleman</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Farah</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ondracek</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wolinsky</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Stroup</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Kruchko</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Barnholtz-Sloan</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010</article-title>
<source/>Neuro Oncol
          <year>2013</year>
<volume>15</volume>
<issue>Suppl 2</issue>
<fpage>ii1</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1093/neuonc/not151</pub-id>
<pub-id pub-id-type="pmid">24137015</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madhusoodanan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Reinharth</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hines</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Serper</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Meningioma and psychiatric symptoms: a case report and brief review</article-title>
<source/>Ann Clin Psychiatry
          <year>2015</year>
<volume>27</volume>
<fpage>126</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="pmid">25954939</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Louis</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Ohgaki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wiestler</surname>
<given-names>OD</given-names>
</name>
<name>
<surname>Cavenee</surname>
<given-names>WK</given-names>
</name>
<name>
<surname>Burger</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Jouvet</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Scheithauer</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Kleihues</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>The 2007 WHO classification of tumours of the central nervous system</article-title>
<source/>Acta Neuropathol
          <year>2007</year>
<volume>114</volume>
<fpage>97</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-007-0243-4</pub-id>
<pub-id pub-id-type="pmid">17618441</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mirimanoff</surname>
<given-names>RO</given-names>
</name>
<name>
<surname>Dosoretz</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Linggood</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Ojemann</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Martuza</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>Meningioma: analysis of recurrence and progression following neurosurgical resection</article-title>
<source/>J Neurosurg
          <year>1985</year>
<volume>62</volume>
<fpage>18</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.3171/jns.1985.62.1.0018</pub-id>
<pub-id pub-id-type="pmid">3964853</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbaro</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Gutin</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Sheline</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Boldrey</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Wara</surname>
<given-names>WM</given-names>
</name>
</person-group>
<article-title>Radiation therapy in the treatment of partially resected meningiomas</article-title>
<source/>Neurosurgery
          <year>1987</year>
<volume>20</volume>
<fpage>525</fpage>
<lpage>528</lpage>
<pub-id pub-id-type="doi">10.1227/00006123-198704000-00003</pub-id>
<pub-id pub-id-type="pmid">3587542</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Boddu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Macarthur</surname>
<given-names>DC</given-names>
</name>
</person-group>
<article-title>Atypical meningiomas: WHO moved the goalposts?</article-title>
<source/>Br J Neurosurg
          <year>2007</year>
<volume>21</volume>
<fpage>588</fpage>
<lpage>592</lpage>
<pub-id pub-id-type="doi">10.1080/02688690701684246</pub-id>
<pub-id pub-id-type="pmid">18071986</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>HW</given-names>
</name>
</person-group>
<article-title>Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features</article-title>
<source/>J Neurol Neurosurg Psychiatry
          <year>2008</year>
<volume>79</volume>
<fpage>574</fpage>
<lpage>580</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.2007.121582</pub-id>
<pub-id pub-id-type="pmid">17766430</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bret</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gharbi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cohadon</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Remond</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Meningioma of the lateral ventricle. 3 recent cases</article-title>
<source/>Neurochirurgie
          <year>1989</year>
<volume>35</volume>
<fpage>5</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">2654684</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruttledge</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Sarrazin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rangaratnam</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Phelan</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Twist</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Merel</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Delattre</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nordenskjold</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>VP</given-names>
</name>
</person-group>
<article-title>Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas</article-title>
<source/>Nat Genet
          <year>1994</year>
<volume>6</volume>
<fpage>180</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="doi">10.1038/ng0294-180</pub-id>
<pub-id pub-id-type="pmid">8162072</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mawrin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Pathological classification and molecular genetics of meningiomas</article-title>
<source/>J Neurooncol
          <year>2010</year>
<volume>99</volume>
<fpage>379</fpage>
<lpage>391</lpage>
<pub-id pub-id-type="doi">10.1007/s11060-010-0342-2</pub-id>
<pub-id pub-id-type="pmid">20809251</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phillips</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Koepsell</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>van</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Kukull</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Gehrels</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Longstreth</surname>
<given-names>WT</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>History of head trauma and risk of intracranial meningioma: population-based case–control study</article-title>
<source/>Neurology
          <year>2002</year>
<volume>58</volume>
<fpage>1849</fpage>
<lpage>1852</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.58.12.1849</pub-id>
<pub-id pub-id-type="pmid">12084890</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Preston-Martin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pogoda</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Schlehofer</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Blettner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Howe</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Menegoz</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Giles</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Rodvall</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>NW</given-names>
</name>
<name>
<surname>Little</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Arslan</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>An international case–control study of adult glioma and meningioma: the role of head trauma</article-title>
<source/>Int J Epidemiol
          <year>1998</year>
<volume>27</volume>
<fpage>579</fpage>
<lpage>586</lpage>
<pub-id pub-id-type="doi">10.1093/ije/27.4.579</pub-id>
<pub-id pub-id-type="pmid">9758110</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossi</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Cruz</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Esiri</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Coakham</surname>
<given-names>HB</given-names>
</name>
</person-group>
<article-title>Immunocytochemical study of the cellular immune response in meningiomas</article-title>
<source/>J Clin Pathol
          <year>1988</year>
<volume>41</volume>
<fpage>314</fpage>
<lpage>319</lpage>
<pub-id pub-id-type="doi">10.1136/jcp.41.3.314</pub-id>
<pub-id pub-id-type="pmid">3258871</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mork</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Nyland</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>An immunohistochemical study of mononuclear cells in meningiomas</article-title>
<source/>Neuropathol Appl Neurobiol
          <year>1992</year>
<volume>18</volume>
<fpage>548</fpage>
<lpage>558</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2990.1992.tb00825.x</pub-id>
<pub-id pub-id-type="pmid">1488087</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kepes</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>WY</given-names>
</name>
<name>
<surname>Connors</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>FS</given-names>
</name>
</person-group>
<article-title>“Chordoid” meningeal tumors in young individuals with peritumoral lymphoplasmacellular infiltrates causing systemic manifestations of the Castleman syndrome. A report of seven cases</article-title>
<source/>Cancer
          <year>1988</year>
<volume>62</volume>
<fpage>391</fpage>
<lpage>406</lpage>
<pub-id pub-id-type="doi">10.1002/1097-0142(19880715)62:2&lt;391::AID-CNCR2820620226&gt;3.0.CO;2-7</pub-id>
<pub-id pub-id-type="pmid">3383139</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajaraman</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Brenner</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Neta</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pfeiffer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Yeager</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fine</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Linet</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Rothman</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chanock</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Inskip</surname>
<given-names>PD</given-names>
</name>
</person-group>
<article-title>Risk of meningioma and common variation in genes related to innate immunity</article-title>
<source/>Cancer Epidemiol Biomarkers Prev
          <year>2010</year>
<volume>19</volume>
<fpage>1356</fpage>
<lpage>1361</lpage>
<pub-id pub-id-type="doi">10.1158/1055-9965.EPI-09-1151</pub-id>
<pub-id pub-id-type="pmid">20406964</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnett</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Bay</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Posttraumatic intracranial meningioma: a case report and review of the literature</article-title>
<source/>Neurosurgery
          <year>1986</year>
<volume>18</volume>
<fpage>75</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1227/00006123-198601000-00012</pub-id>
<pub-id pub-id-type="pmid">3945379</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kunz</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Marklund</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hillered</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Oliw</surname>
<given-names>EH</given-names>
</name>
</person-group>
<article-title>Cyclooxygenase-2, prostaglandin synthases, and prostaglandin H2 metabolism in traumatic brain injury in the rat</article-title>
<source/>J Neurotrauma
          <year>2002</year>
<volume>19</volume>
<fpage>1051</fpage>
<lpage>1064</lpage>
<pub-id pub-id-type="doi">10.1089/089771502760341965</pub-id>
<pub-id pub-id-type="pmid">12482118</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ragel</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Couldwell</surname>
<given-names>WT</given-names>
</name>
</person-group>
<article-title>Inflammatory response and meningioma tumorigenesis and the effect of cyclooxygenase-2 inhibitors</article-title>
<source/>Neurosurg Focus
          <year>2007</year>
<volume>23</volume>
<fpage>E7</fpage>
<pub-id pub-id-type="doi">10.3171/FOC-07/10/E7</pub-id>
<pub-id pub-id-type="pmid">17961044</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reszec</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hermanowicz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kochanowicz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Turek</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mariak</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Chyczewski</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Mast cells evaluation in meningioma of various grades</article-title>
<source/>Folia Histochem Cytobiol
          <year>2012</year>
<volume>50</volume>
<fpage>542</fpage>
<lpage>546</lpage>
<pub-id pub-id-type="doi">10.5603/FHC.2012.0076</pub-id>
<pub-id pub-id-type="pmid">23264217</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lolova</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ivanova</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>A histochemical study of meningiomas</article-title>
<source/>Acta Neuropathol
          <year>1972</year>
<volume>20</volume>
<fpage>110</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.1007/BF00691128</pub-id>
<pub-id pub-id-type="pmid">4259676</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Popovic</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Lyons</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Scheithauer</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Marsh</surname>
<given-names>WR</given-names>
</name>
</person-group>
<article-title>Mast cell-rich convexity meningioma presenting as chronic subdural hematoma: case report and review of the literature</article-title>
<source/>Surg Neurol
          <year>1994</year>
<volume>42</volume>
<fpage>8</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1016/0090-3019(94)90242-9</pub-id>
<pub-id pub-id-type="pmid">7524172</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tascos</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Parr</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gonatas</surname>
<given-names>NK</given-names>
</name>
</person-group>
<article-title>Immunocytochemical study of the glial fibrillary acidic protein in human neoplasms of the central nervous system</article-title>
<source/>Hum Pathol
          <year>1982</year>
<volume>13</volume>
<fpage>454</fpage>
<lpage>458</lpage>
<pub-id pub-id-type="doi">10.1016/S0046-8177(82)80028-2</pub-id>
<pub-id pub-id-type="pmid">6281168</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christie</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Stoward</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>Endogenous peroxidase in mast cells localized with a semipermeable membrane technique</article-title>
<source/>Histochem J
          <year>1978</year>
<volume>10</volume>
<fpage>425</fpage>
<lpage>433</lpage>
<pub-id pub-id-type="doi">10.1007/BF01003006</pub-id>
<pub-id pub-id-type="pmid">669984</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reszec</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hermanowicz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rutkowski</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bernaczyk</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mariak</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Chyczewski</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Evaluation of mast cells and hypoxia inducible factor-1 expression in meningiomas of various grades in correlation with peritumoral brain edema</article-title>
<source/>J Neurooncol
          <year>2013</year>
<volume>115</volume>
<fpage>119</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="doi">10.1007/s11060-013-1208-1</pub-id>
<pub-id pub-id-type="pmid">23877362</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jabini</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Moradi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Afsharnezhad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ayatollahi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Behravan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Raziee</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Mosaffa</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Pathodiagnostic parameters and evaluation of O(6)- methyl guanine methyl transferase gene promoter methylation in meningiomas</article-title>
<source/>Gene
          <year>2014</year>
<volume>538</volume>
<fpage>348</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="doi">10.1016/j.gene.2013.12.039</pub-id>
<pub-id pub-id-type="pmid">24398011</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilfillan</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Austin</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Metcalfe</surname>
<given-names>DD</given-names>
</name>
</person-group>
<article-title>Mast cell biology: introduction and overview</article-title>
<source/>Adv Exp Med Biol
          <year>2011</year>
<volume>716</volume>
<fpage>2</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-4419-9533-9_1</pub-id>
<pub-id pub-id-type="pmid">21713648</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribatti</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Crivellato</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Mast cells, angiogenesis, and tumour growth</article-title>
<source/>Biochim Biophys Acta
          <year>1822</year>
<volume>2012</volume>
<fpage>2</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Mast cells: the JEKYLL and HYDE of tumor growth</article-title>
<source/>Trends Immunol
          <year>2004</year>
<volume>25</volume>
<fpage>235</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="doi">10.1016/j.it.2004.02.013</pub-id>
<pub-id pub-id-type="pmid">15099563</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<mixed-citation publication-type="other">Theoharides TC, Valent P, Akin C. Mast cells, mastocytosis and related diseases. New Engl J Med<italic>.</italic> 2015. in press</mixed-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<mixed-citation publication-type="other">Theoharides TC, Stewart JM, Panagiotidou S. Mast Cells, Brain Inflammation and Autism. Eur J Pharmacol. 2015. in press</mixed-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dimitriadou</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Rouleau</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Trung Tuong</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Newlands</surname>
<given-names>GJF</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>HRP</given-names>
</name>
<name>
<surname>Luffau</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>J-C</given-names>
</name>
<name>
<surname>Garbarg</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions</article-title>
<source/>Neuroscience
          <year>1997</year>
<volume>77</volume>
<fpage>829</fpage>
<lpage>839</lpage>
<pub-id pub-id-type="doi">10.1016/S0306-4522(96)00488-5</pub-id>
<pub-id pub-id-type="pmid">9070755</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<mixed-citation publication-type="other">Silver R, Curley JP. Mast cells on the mind: new insights and opportunities. Trends Neurosci. 2013.</mixed-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Angelidou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Alysandratos</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Asadi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Toniato</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kalogeromitros</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Mast cell activation and autism</article-title>
<source/>Biochim Biophys Acta
          <year>1822</year>
<volume>2012</volume>
<fpage>34</fpage>
<lpage>41</lpage>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Mast cells: the immune gate to the brain</article-title>
<source/>Life Sci
          <year>1990</year>
<volume>46</volume>
<fpage>607</fpage>
<lpage>617</lpage>
<pub-id pub-id-type="doi">10.1016/0024-3205(90)90129-F</pub-id>
<pub-id pub-id-type="pmid">2407920</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Konstantinidou</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Corticotropin-releasing hormone and the blood-brain-barrier</article-title>
<source/>Front Biosci
          <year>2007</year>
<volume>12</volume>
<fpage>1615</fpage>
<lpage>1628</lpage>
<pub-id pub-id-type="doi">10.2741/2174</pub-id>
<pub-id pub-id-type="pmid">17127408</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esposito</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chandler</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kandere-Grzybowska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Connolly</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tutor</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Corticotropin-releasing hormone (CRH) and brain mast cells regulate blood-brain-barrier permeability induced by acute stress</article-title>
<source/>J Pharmacol Exp Ther
          <year>2002</year>
<volume>303</volume>
<fpage>1061</fpage>
<lpage>1066</lpage>
<pub-id pub-id-type="doi">10.1124/jpet.102.038497</pub-id>
<pub-id pub-id-type="pmid">12438528</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Kalogeromitros</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The critical role of mast cell in allergy and inflammation</article-title>
<source/>Ann NY Acad Sci
          <year>2006</year>
<volume>1088</volume>
<fpage>78</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1196/annals.1366.025</pub-id>
<pub-id pub-id-type="pmid">17192558</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<mixed-citation publication-type="other">Ribatti D. The crucial role of mast cells in blood-brain barrier alterations. Exp Cell Res. 2015.</mixed-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelissen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lemmens</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Geurts</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Maurer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hendriks</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hendrix</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>The role of mast cells in neuroinflammation</article-title>
<source/>Acta Neuropathol
          <year>2013</year>
<volume>125</volume>
<fpage>637</fpage>
<lpage>650</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-013-1092-y</pub-id>
<pub-id pub-id-type="pmid">23404369</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skaper</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Facci</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Giusti</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Mast cells, glia and neuroinflammation: partners in crime?</article-title>
<source/>Immunology
          <year>2014</year>
<volume>141</volume>
<fpage>314</fpage>
<lpage>327</lpage>
<pub-id pub-id-type="doi">10.1111/imm.12170</pub-id>
<pub-id pub-id-type="pmid">24032675</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Neuro-Inflammation, blood-brain barrier, seizures and autism</article-title>
<source/>J Neuroinflammation
          <year>2011</year>
<volume>8</volume>
<fpage>168</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-8-168</pub-id>
<pub-id pub-id-type="pmid">22129087</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skaper</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Facci</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Giusti</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Mast cells, glia and neuroinflammation: partners in crime?</article-title>
<source/>Immunology
          <year>2014</year>
<volume>141</volume>
<fpage>314</fpage>
<lpage>327</lpage>
<pub-id pub-id-type="doi">10.1111/imm.12170</pub-id>
<pub-id pub-id-type="pmid">24032675</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Donelan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kandere-Grzybowska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Konstantinidou</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The role of mast cells in migraine pathophysiology</article-title>
<source/>Brain Res Rev
          <year>2005</year>
<volume>49</volume>
<fpage>65</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainresrev.2004.11.006</pub-id>
<pub-id pub-id-type="pmid">15960987</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Asadi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Focal brain inflammation and autism</article-title>
<source/>J Neuroinflammation
          <year>2013</year>
<volume>10</volume>
<fpage>46</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-10-46</pub-id>
<pub-id pub-id-type="pmid">23570274</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasiadi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Newman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Isoflavones inhibit poly(I:C)-induced serum, brain, and skin inflammatory mediators - relevance to chronic fatigue syndrome</article-title>
<source/>J Neuroinflammation
          <year>2014</year>
<volume>11</volume>
<fpage>168</fpage>
<pub-id pub-id-type="doi">10.1186/s12974-014-0168-5</pub-id>
<pub-id pub-id-type="pmid">25359293</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoogland</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Houbolt</surname>
<given-names>C</given-names>
</name>
<name>
<surname>van Westerloo</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>van Gool</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>van de</surname>
<given-names>BD</given-names>
</name>
</person-group>
<article-title>Systemic inflammation and microglial activation: systematic review of animal experiments</article-title>
<source/>J Neuroinflammation
          <year>2015</year>
<volume>12</volume>
<fpage>114</fpage>
<pub-id pub-id-type="doi">10.1186/s12974-015-0332-6</pub-id>
<pub-id pub-id-type="pmid">26048578</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<mixed-citation publication-type="other">Ribatti D. Mast cells as therapeutic target in cancer. Eur J Pharmacol. 2015</mixed-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polajeva</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sjosten</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Lager</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kastemar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Waern</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Alafuzoff</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Smits</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Westermark</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pejler</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Uhrbom</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tchougounova</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<fpage>e25222</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0025222</pub-id>
<pub-id pub-id-type="pmid">21949886</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polajeva</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bergstrom</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Edqvist</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Lundequist</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sjosten</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nilsson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Smits</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bergqvist</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ponten</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Westermark</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pejler</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Forsberg</surname>
<given-names>NK</given-names>
</name>
<name>
<surname>Tchougounova</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner</article-title>
<source/>Mol Oncol
          <year>2014</year>
<volume>8</volume>
<fpage>50</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1016/j.molonc.2013.09.002</pub-id>
<pub-id pub-id-type="pmid">24091309</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Marsden</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Earnshaw</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Weibel-Palade bodies in endothelial cells as a marker for angiogenesis in brain tumors</article-title>
<source/>Cancer Res
          <year>1980</year>
<volume>40</volume>
<fpage>2010</fpage>
<lpage>2019</lpage>
<pub-id pub-id-type="pmid">6154535</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tachibana</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Yamashima</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Immunohistochemical study of erythropoietin in cerebellar hemangioblastomas associated with secondary polycythemia</article-title>
<source/>Neurosurgery
          <year>1991</year>
<volume>28</volume>
<fpage>24</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1227/00006123-199101000-00004</pub-id>
<pub-id pub-id-type="pmid">1994278</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Rozniecki</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Sahagian</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kempuraj</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kalogeromitros</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Impact of stress and mast cells on brain metastases</article-title>
<source/>J Neuroimmunol
          <year>2008</year>
<volume>205</volume>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2008.09.014</pub-id>
<pub-id pub-id-type="pmid">18977036</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esposito</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Connolly</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gheorghe</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Non-invasive assessment of blood-brain barrier (BBB) permeability using a gamma camera to detect <sup>99</sup>Technetium-gluceptate extravasation in rat brain</article-title>
<source/>Brain Res Protocols
          <year>2001</year>
<volume>8</volume>
<fpage>143</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="doi">10.1016/S1385-299X(01)00104-0</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rozniecki</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Sahagian</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Kempuraj</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Jocobson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Brain metastases of mouse mammary adenocarcinoma is increased by acute stress</article-title>
<source/>Brain Res
          <year>2010</year>
<volume>1366</volume>
<fpage>204</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2010.09.085</pub-id>
<pub-id pub-id-type="pmid">20887716</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sayegh</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Henderson</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Burch</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bloch</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Parsa</surname>
<given-names>AT</given-names>
</name>
</person-group>
<article-title>Intrameningioma metastasis of breast carcinoma</article-title>
<source/>Rare Tumors
          <year>2014</year>
<volume>6</volume>
<fpage>5313</fpage>
<pub-id pub-id-type="doi">10.4081/rt.2014.5313</pub-id>
<pub-id pub-id-type="pmid">25002947</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okada</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Koshida</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mukai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Toyama</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Breast carcinoma metastasis to meningioma in the thoracic spine: a case report and review of the literature</article-title>
<source/>J Spinal Cord Med
          <year>2015</year>
<volume>38</volume>
<fpage>231</fpage>
<lpage>235</lpage>
<pub-id pub-id-type="doi">10.1179/2045772314Y.0000000201</pub-id>
<pub-id pub-id-type="pmid">24617535</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<mixed-citation publication-type="other">Milano MT, Grossman CE. Meningioma in breast cancer patients: population-based analysis of clinicopathologic characteristics. Am J Clin Oncol. 2014</mixed-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Mast cells and pancreatic cancer</article-title>
<source/>N Engl J Med
          <year>2008</year>
<volume>358</volume>
<fpage>1860</fpage>
<lpage>1861</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMcibr0801519</pub-id>
<pub-id pub-id-type="pmid">18434656</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target</article-title>
<source/>J Neurooncol
          <year>2009</year>
<volume>92</volume>
<fpage>317</fpage>
<lpage>335</lpage>
<pub-id pub-id-type="doi">10.1007/s11060-009-9827-2</pub-id>
<pub-id pub-id-type="pmid">19357959</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kazner</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lanksch</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Steinhoff</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wilske</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Computerized axial tomography of the skull - diagnostic possibilities and clinical results (author’s transl)</article-title>
<source/>Fortschr Neurol Psychiatr Grenzgeb
          <year>1975</year>
<volume>43</volume>
<fpage>487</fpage>
<lpage>574</lpage>
<pub-id pub-id-type="pmid">171202</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tirakotai</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Mennel</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Celik</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hellwig</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bertalanffy</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Riegel</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Secretory meningioma: immunohistochemical findings and evaluation of mast cell infiltration</article-title>
<source/>Neurosurg Rev
          <year>2006</year>
<volume>29</volume>
<fpage>41</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1007/s10143-005-0402-9</pub-id>
<pub-id pub-id-type="pmid">16010579</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Epari</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>VS</given-names>
</name>
</person-group>
<article-title>Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases</article-title>
<source/>J Neurooncol
          <year>2006</year>
<volume>78</volume>
<fpage>263</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1007/s11060-005-9092-y</pub-id>
<pub-id pub-id-type="pmid">16628477</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tena-Suck</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Collado-Ortiz</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Salinas-Lara</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Garcia-Lopez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gelista</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rembao-Bojorquez</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Chordoid meningioma: a report of ten cases</article-title>
<source/>J Neurooncol
          <year>2010</year>
<volume>99</volume>
<fpage>41</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1007/s11060-009-0097-9</pub-id>
<pub-id pub-id-type="pmid">20094774</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schober</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Himuro</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wechsler</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Cystic changes and vascular permeability in meningiomas</article-title>
<source/>Clin Neuropathol
          <year>1988</year>
<volume>7</volume>
<fpage>16</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="pmid">3370860</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karamitopoulou</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Shoni</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Increased number of non-degranulated mast cells in pancreatic ductal adenocarcinoma but not in acute pancreatitis</article-title>
<source/>Int J Immunopathol Pharmacol
          <year>2014</year>
<volume>27</volume>
<fpage>213</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="pmid">25004833</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abe</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Ojemann</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Hedley-White</surname>
<given-names>ET</given-names>
</name>
</person-group>
<article-title>Cerebral edema in intracranial meningiomas: evidence for local and diffuse patterns and factors associated with its occurrence</article-title>
<source/>Surg Neurol
          <year>1994</year>
<volume>42</volume>
<fpage>471</fpage>
<lpage>475</lpage>
<pub-id pub-id-type="doi">10.1016/0090-3019(94)90075-2</pub-id>
<pub-id pub-id-type="pmid">7825100</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buhl</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hugo</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Mehdorn</surname>
<given-names>HM</given-names>
</name>
</person-group>
<article-title>Brain oedema in secretory meningiomas</article-title>
<source/>J Clin Neurosci
          <year>2001</year>
<volume>8</volume>
<issue>Suppl 1</issue>
<fpage>19</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1054/jocn.2001.0871</pub-id>
<pub-id pub-id-type="pmid">11386820</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wick</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kuker</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Brain edema in neurooncology: radiological assessment and management</article-title>
<source/>Onkologie
          <year>2004</year>
<volume>27</volume>
<fpage>261</fpage>
<lpage>266</lpage>
<pub-id pub-id-type="doi">10.1159/000077976</pub-id>
<pub-id pub-id-type="pmid">15249715</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakano</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Asano</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Meningiomas with brain edema: radiological characteristics on MRI and review of the literature</article-title>
<source/>Clin Imaging
          <year>2002</year>
<volume>26</volume>
<fpage>243</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="doi">10.1016/S0899-7071(02)00433-3</pub-id>
<pub-id pub-id-type="pmid">12140153</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Machein</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Plate</surname>
<given-names>KH</given-names>
</name>
</person-group>
<article-title>VEGF in brain tumors</article-title>
<source/>J Neurooncol
          <year>2000</year>
<volume>50</volume>
<fpage>109</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">10.1023/A:1006416003964</pub-id>
<pub-id pub-id-type="pmid">11245271</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nassehi</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema</article-title>
<source/>Dan Med J
          <year>2013</year>
<volume>60</volume>
<fpage>B4626</fpage>
<pub-id pub-id-type="pmid">23651727</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kshettry</surname>
<given-names>VR</given-names>
</name>
<name>
<surname>Selman</surname>
<given-names>WR</given-names>
</name>
<name>
<surname>Bambakidis</surname>
<given-names>NC</given-names>
</name>
</person-group>
<article-title>Peritumoral brain edema in intracranial meningiomas: the emergence of vascular endothelial growth factor-directed therapy</article-title>
<source/>Neurosurg Focus
          <year>2013</year>
<volume>35</volume>
<fpage>E2</fpage>
<pub-id pub-id-type="doi">10.3171/2013.8.FOCUS13301</pub-id>
<pub-id pub-id-type="pmid">24289127</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Papadopoulou</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kempuraj</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Boucher</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Sugimoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cetrulo</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor</article-title>
<source/>J Immunol
          <year>2005</year>
<volume>174</volume>
<fpage>7665</fpage>
<lpage>7675</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.174.12.7665</pub-id>
<pub-id pub-id-type="pmid">15944267</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kempuraj</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Papadopoulou</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Lytinas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kandere-Grzybowska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Madhappan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Boucher</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Athanassiou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells</article-title>
<source/>Endocrinology
          <year>2004</year>
<volume>145</volume>
<fpage>43</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1210/en.2003-0805</pub-id>
<pub-id pub-id-type="pmid">14576187</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shahani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nudelman</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Nalini</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Samson</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Ectopic corticotropin-releasing hormone (CRH) syndrome from metastatic small cell carcinoma: a case report and review of the literature</article-title>
<source/>Diagn Pathol
          <year>2010</year>
<volume>5</volume>
<fpage>56</fpage>
<pub-id pub-id-type="doi">10.1186/1746-1596-5-56</pub-id>
<pub-id pub-id-type="pmid">20807418</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feoktistov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Diamond</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Diagnosing and understanding adult headache</article-title>
<source/>Otolaryngol Clin North Am
          <year>2014</year>
<volume>47</volume>
<fpage>175</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="doi">10.1016/j.otc.2013.10.004</pub-id>
<pub-id pub-id-type="pmid">24680487</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<mixed-citation publication-type="other">Smith RM, Robertson CE, Garza I. Orthostatic headache from supratentorial meningioma. Cephalalgia. 2015</mixed-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heron</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dubayle</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>A focus on mast cells and pain</article-title>
<source/>J Neuroimmunol
          <year>2013</year>
<volume>264</volume>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2013.09.018</pub-id>
<pub-id pub-id-type="pmid">24125568</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hancock</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Dandona</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cumberland</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Jarratt</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Systemic mastocytosis--central nervous system features and lymphographic demonstration of lymph node involvement</article-title>
<source/>Postgrad Med J
          <year>1976</year>
<volume>52</volume>
<fpage>659</fpage>
<lpage>662</lpage>
<pub-id pub-id-type="doi">10.1136/pgmj.52.612.659</pub-id>
<pub-id pub-id-type="pmid">995794</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ransohoff</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Immunology: barrier to electrical storms</article-title>
<source/>Nature
          <year>2009</year>
<volume>457</volume>
<fpage>155</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1038/457155a</pub-id>
<pub-id pub-id-type="pmid">19129836</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pehlivanidis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fotoulaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Boucher</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kempuraj</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Konstantinidou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Acute stress-induced seizures and loss of consciousness in a ten-year-old boy with cutaneous mastocytosis</article-title>
<source/>J Clin Psychopharmacol
          <year>2002</year>
<volume>22</volume>
<fpage>221</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="doi">10.1097/00004714-200204000-00019</pub-id>
<pub-id pub-id-type="pmid">11910271</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karagkouni</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Alevizos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Effect of stress on brain inflammation and multiple sclerosis</article-title>
<source/>Autoimmun Rev
          <year>2013</year>
<volume>12</volume>
<fpage>947</fpage>
<lpage>953</lpage>
<pub-id pub-id-type="doi">10.1016/j.autrev.2013.02.006</pub-id>
<pub-id pub-id-type="pmid">23537508</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bradstreet</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Pacini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ruggiero</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>A new methodology of viewing extra-axial fluid and cortical abnormalities in children with autism via transcranial ultrasonography</article-title>
<source/>Front Hum Neurosci
          <year>2014</year>
<volume>7</volume>
<fpage>934</fpage>
<pub-id pub-id-type="doi">10.3389/fnhum.2013.00934</pub-id>
<pub-id pub-id-type="pmid">24459462</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<mixed-citation publication-type="other">Theoharides TC, Stewart JM, Hatziagelaki E, Kolaitis G. Brain “fog,” inflammation and obesity: key aspects of 2 neuropsychiatric disorders improved by luteolin. Front. Neurosci. 2015. in press</mixed-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roth</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Regli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tonder</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Weller</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Tumor-associated edema in brain cancer patients: pathogenesis and management</article-title>
<source/>Expert Rev Anticancer Ther
          <year>2013</year>
<volume>13</volume>
<fpage>1319</fpage>
<lpage>1325</lpage>
<pub-id pub-id-type="doi">10.1586/14737140.2013.852473</pub-id>
<pub-id pub-id-type="pmid">24152171</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Temel</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Kahveci</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Cyclooxygenase-2 expression in astrocytes and microglia in human oligodendroglioma and astrocytoma</article-title>
<source/>J Mol Histol
          <year>2009</year>
<volume>40</volume>
<fpage>369</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.1007/s10735-009-9250-1</pub-id>
<pub-id pub-id-type="pmid">20052522</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<fpage>e22934</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0022934</pub-id>
<pub-id pub-id-type="pmid">21857970</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Pascual-Teresa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>DuPont</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>O’Leary</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Needs</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Clifford</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Quercetin metabolites downregulate cyclooxygenase-2 transcription in human lymphocytes ex vivo but not in vivo</article-title>
<source/>J Nutr
          <year>2004</year>
<volume>134</volume>
<fpage>552</fpage>
<lpage>557</lpage>
<pub-id pub-id-type="pmid">14988445</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Moldovan</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Ben</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Annabi</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Biphasic effects of luteolin on interleukin-1beta-induced cyclooxygenase-2 expression in glioblastoma cells</article-title>
<source/>Biochim Biophys Acta
          <year>1853</year>
<volume>2015</volume>
<fpage>126</fpage>
<lpage>135</lpage>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piantelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rinelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Macri</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Maggiano</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Larocca</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Scerrati</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Roselli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Iacoangeli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Scambia</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Capelli</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas</article-title>
<source/>Cancer
          <year>1993</year>
<volume>71</volume>
<fpage>193</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="doi">10.1002/1097-0142(19930101)71:1&lt;193::AID-CNCR2820710130&gt;3.0.CO;2-C</pub-id>
<pub-id pub-id-type="pmid">8416715</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>dS</given-names>
</name>
</person-group>
<article-title>Quercetin-induced downregulation of phospholipase D1 inhibits proliferation and invasion in U87 glioma cells</article-title>
<source/>Biochem Biophys Res Commun
          <year>2011</year>
<volume>412</volume>
<fpage>710</fpage>
<lpage>715</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2011.08.037</pub-id>
<pub-id pub-id-type="pmid">21867678</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braganhol</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zamin</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Canedo</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Horn</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tamajusuku</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Wink</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Salbego</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Battastini</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Antiproliferative effect of quercetin in the human U138MG glioma cell line</article-title>
<source/>Anticancer Drugs
          <year>2006</year>
<volume>17</volume>
<fpage>663</fpage>
<lpage>671</lpage>
<pub-id pub-id-type="doi">10.1097/01.cad.0000215063.23932.02</pub-id>
<pub-id pub-id-type="pmid">16917212</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeon</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Suh</surname>
<given-names>YJ</given-names>
</name>
</person-group>
<article-title>Synergistic apoptotic effect of celecoxib and luteolin on breast cancer cells</article-title>
<source/>Oncol Rep
          <year>2013</year>
<volume>29</volume>
<fpage>819</fpage>
<lpage>825</lpage>
<pub-id pub-id-type="pmid">23229294</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kempuraj</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Madhappan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Boucher</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Papadopoulou</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Cetrulo</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells</article-title>
<source/>Br J Pharmacol
          <year>2005</year>
<volume>145</volume>
<fpage>934</fpage>
<lpage>944</lpage>
<pub-id pub-id-type="doi">10.1038/sj.bjp.0706246</pub-id>
<pub-id pub-id-type="pmid">15912140</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kimata</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shichijo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Serizawa</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Inagaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nagai</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells</article-title>
<source/>Clin Exp Allergy
          <year>2000</year>
<volume>30</volume>
<fpage>501</fpage>
<lpage>508</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2222.2000.00768.x</pub-id>
<pub-id pub-id-type="pmid">10718847</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asadi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Angelidou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kempuraj</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Alysandratos</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Luteolin and thiosalicylate inhibit HgCl(2) and thimerosal-induced VEGF release from human mast cells</article-title>
<source/>Int J Immunopathol Pharmacol
          <year>2010</year>
<volume>23</volume>
<fpage>1015</fpage>
<lpage>1020</lpage>
<pub-id pub-id-type="pmid">21244751</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kempuraj</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tagen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Iliopoulou</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Clemons</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vasiadi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Boucher</surname>
<given-names>W</given-names>
</name>
<name>
<surname>House</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wolferg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell dependent stimulation of Jurkat T cells</article-title>
<source/>Br J Pharmacol
          <year>2008</year>
<volume>155</volume>
<fpage>1076</fpage>
<lpage>1084</lpage>
<pub-id pub-id-type="doi">10.1038/bjp.2008.356</pub-id>
<pub-id pub-id-type="pmid">18806808</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verbeek</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Plomp</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>van Tol</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>van Noort</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells</article-title>
<source/>Biochem Pharmacol
          <year>2004</year>
<volume>68</volume>
<fpage>621</fpage>
<lpage>629</lpage>
<pub-id pub-id-type="doi">10.1016/j.bcp.2004.05.012</pub-id>
<pub-id pub-id-type="pmid">15276069</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shim</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Byun</surname>
<given-names>DS</given-names>
</name>
</person-group>
<article-title>6-Methoxyluteolin from Chrysanthemum zawadskii var. latilobum suppresses histamine release and calcium influx via down-regulation of FcepsilonRI alpha chain expression</article-title>
<source/>J Microbiol Biotechnol
          <year>2012</year>
<volume>22</volume>
<fpage>622</fpage>
<lpage>627</lpage>
<pub-id pub-id-type="doi">10.4014/jmb.1111.11060</pub-id>
<pub-id pub-id-type="pmid">22561855</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weng</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Panagiotidou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Theoharidess</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells</article-title>
<source/>J Allergy Clin Immunol
          <year>2014</year>
<volume>14</volume>
<fpage>1044</fpage>
<lpage>1052</lpage>
<pub-id pub-id-type="pmid">25498791</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>RW</given-names>
</name>
</person-group>
<article-title>Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2008</year>
<volume>105</volume>
<fpage>7534</fpage>
<lpage>7539</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0802865105</pub-id>
<pub-id pub-id-type="pmid">18490655</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dirscherl</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Karlstetter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ebert</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kraus</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hlawatsch</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Walczak</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Moehle</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fuchshofer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Langmann</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype</article-title>
<source/>J Neuroinflammation
          <year>2010</year>
<volume>7</volume>
<fpage>3</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-7-3</pub-id>
<pub-id pub-id-type="pmid">20074346</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>HQ</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>ZY</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>XJ</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>XM</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation</article-title>
<source/>Neurosci Lett
          <year>2008</year>
<volume>448</volume>
<fpage>175</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2008.10.046</pub-id>
<pub-id pub-id-type="pmid">18952146</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kao</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Ou</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Raung</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>Luteolin inhibits cytokine expression in endotoxin/cytokine-stimulated microglia</article-title>
<source/>J Nutr Biochem
          <year>2011</year>
<volume>22</volume>
<fpage>612</fpage>
<lpage>624</lpage>
<pub-id pub-id-type="doi">10.1016/j.jnutbio.2010.01.011</pub-id>
<pub-id pub-id-type="pmid">21036586</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Ashar</surname>
<given-names>FN</given-names>
</name>
<name>
<surname>Moes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bader</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>West</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Arking</surname>
<given-names>DE</given-names>
</name>
</person-group>
<article-title>Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism</article-title>
<source/>Nat Commun
          <year>2014</year>
<volume>5</volume>
<fpage>5748</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms6748</pub-id>
<pub-id pub-id-type="pmid">25494366</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Asadi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Panagiotidou</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>A case series of a luteolin formulation (NeuroProtek(R)) in children with autism spectrum disorders</article-title>
<source/>Int J Immunopathol Pharmacol
          <year>2012</year>
<volume>25</volume>
<fpage>317</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="pmid">22697063</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taliou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zintzaras</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lykouras</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders</article-title>
<source/>Clin Ther
          <year>2013</year>
<volume>35</volume>
<fpage>592</fpage>
<lpage>602</lpage>
<pub-id pub-id-type="doi">10.1016/j.clinthera.2013.04.006</pub-id>
<pub-id pub-id-type="pmid">23688534</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beauchamp</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Keast</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Morel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pika</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Breslin</surname>
<given-names>PA</given-names>
</name>
</person-group>
<article-title>Phytochemistry: ibuprofen-like activity in extra-virgin olive oil</article-title>
<source/>Nature
          <year>2005</year>
<volume>437</volume>
<fpage>45</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1038/437045a</pub-id>
<pub-id pub-id-type="pmid">16136122</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Middleton</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Kandaswami</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer</article-title>
<source/>Pharmacol Rev
          <year>2000</year>
<volume>52</volume>
<fpage>673</fpage>
<lpage>751</lpage>
<pub-id pub-id-type="pmid">11121513</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jager</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Saaby</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Flavonoids and the CNS</article-title>
<source/>Molecules
          <year>2011</year>
<volume>16</volume>
<fpage>1471</fpage>
<lpage>1485</lpage>
<pub-id pub-id-type="doi">10.3390/molecules16021471</pub-id>
<pub-id pub-id-type="pmid">21311414</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grosso</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Valentao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ferreres</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Andrade</surname>
<given-names>PB</given-names>
</name>
</person-group>
<article-title>The use of flavonoids in central nervous system disorders</article-title>
<source/>Curr Med Chem
          <year>2013</year>
<volume>20</volume>
<fpage>4697</fpage>
<lpage>4719</lpage>
<pub-id pub-id-type="doi">10.2174/09298673113209990155</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solanki</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Parihar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mansuri</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Parihar</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Flavonoid-based therapies in the early management of neurodegenerative diseases</article-title>
<source/>Adv Nutr
          <year>2015</year>
<volume>6</volume>
<fpage>64</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.3945/an.114.007500</pub-id>
<pub-id pub-id-type="pmid">25593144</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>QR</given-names>
</name>
<name>
<surname>Warford</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rupasinghe</surname>
<given-names>HP</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>GS</given-names>
</name>
</person-group>
<article-title>Target-based selection of flavonoids for neurodegenerative disorders</article-title>
<source/>Trends Pharmacol Sci
          <year>2012</year>
<volume>33</volume>
<fpage>602</fpage>
<lpage>610</lpage>
<pub-id pub-id-type="doi">10.1016/j.tips.2012.08.002</pub-id>
<pub-id pub-id-type="pmid">22980637</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Hatziagelaki</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kolaitis</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Brain “fog”, inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin</article-title>
<source/>Front Neurosci
          <year>2015</year>
<volume>9</volume>
<fpage>225</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2015.00225</pub-id>
<pub-id pub-id-type="pmid">26190965</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>